Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ABBV
AbbVie Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
ABBV
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.5%
▲
+1.41%
×0.40
Q2 FY26
±3.5%
▼
−2.51%
×0.71
= implied
LLY realized, solid
ABBV realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.0%
▲
+3.14%
×0.78
Feb 4 '26
±3.9%
▼
−3.79%
×0.97
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,352.40
· delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ABBV
AbbVie Inc.
Change
287.91
· pre 283.14
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$521.1B
Revenue
$17.4B
Q3 FY26
Revenue
$61.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
LLY
ELI Lilly & Co
vs
ABBV
AbbVie Inc.
1,371.32
pre 1,352.40
delayed
Price
287.91
pre 283.14
delayed
$1.2T
Mkt cap
$521.1B
Q3 FY26
$24.4B
Revenue
$17.4B
Q3 FY26
FY25
$65.2B
Revenue
$61.2B
FY25
Change
Change
LLY
1,371.32
vs
ABBV
287.91
Pre-market
Nov 6 '26
delayed